Sorting by: liverank (All)
Date
Rank
Live rank
Popular

News tagged with crizotinib

Existing drug shows promise treating most prevalent type of lung cancer

Jul 19, 2023

Patient-reported outcomes from the randomized phase III CROWN study of first-line Lorlatinib versus in ALK+ NSCLC

Jan 31, 2021

Phase 3 eXalt3 study shows significantly longer progression-free survival

Aug 8, 2020

Entrectinib gets edge over crizotinib against ROS1+ lung cancer

May 30, 2019

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

Sep 25, 2018

ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC

Jun 3, 2018

Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer

Apr 12, 2018

Study shows alectinib 600 mg more effective than crizotinib in Asian cancer patients

Nov 17, 2017

Alectinib halts lung cancer growth more than a year longer than crizotinib

Jun 5, 2017

"Liquid biopsy" may help earlier detection of lung cancer treatment resistance

Apr 20, 2015
Load more